G. Landis
Fortune : 746 296 $ au 31/05/2026
Fortune : 746 296 $ au 31/05/2026
G.
Michael Landis is Chief Financial Officer & Director at Polaryx Therapeutics, Inc. since 2025.
Former roles include Chief Accounting Officer at Lannett Co., Inc. from 2009 to 2013, Chief Financial Officer at Avisa Diagnostics, Inc. in 2021, and Chief Accounting Officer at Allied Security Holdings LLC.
Also served as Chief Financial Officer at Epygenix Therapeutics, Inc. Education includes undergraduate studies at Franklin & Marshall College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/02/2026 | 228 225 ( 0,48 % ) | 746 296 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| POLARYX THERAPEUTICS, INC. | Directeur Financier/CFO | 01/06/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| AVISA DIAGNOSTICS INC. | Directeur Financier/CFO | 01/12/2021 |
| LANNETT COMPANY, INC. | Comptroller/Controller/Auditor | 13/07/2020 |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Directeur Financier/CFO | - |
Allied Security Holdings LLC
Allied Security Holdings LLC Miscellaneous Commercial ServicesCommercial Services Provides security guards and patrol services | Comptroller/Controller/Auditor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Lannett Co., Inc.
Lannett Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies generic pharmaceutical products | Health Technology |
Allied Security Holdings LLC
Allied Security Holdings LLC Miscellaneous Commercial ServicesCommercial Services Provides security guards and patrol services | Commercial Services |
Franklin & Marshall College
Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Polaryx Therapeutics, Inc.
Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
Avisa Diagnostics, Inc.
Avisa Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national